|
Alberta is pressing pause on a trial studying whether the controversial drug hydroxychloroquine can effectively treat COVID-19, after new data suggests the drug could do more harm than good. A study published last week in The Lancet, a peer-reviewed medical journal, suggested that hydroxychloroquine is associated with a higher risk of severe outcomes including death in patients hospitalized with COVID-19.
|